Libride D

Libride D is a multi-ingredient tablet formulation combining Chlordiazepoxide, a benzodiazepine with antianxiety properties, Clidinium Bromide, an anticholinergic agent, and Dicyclomine Hydrochloride, an antispasmodic. The formulation is engineered to ensure compatibility, stability, and uniform dispersion of active ingredients. Each tablet is designed for rapid disintegration and dissolution, ensuring consistent bioavailability. The combination of these three components requires precise excipient selection to prevent chemical interactions, with particular attention to pH stability and solubility profiles. The tablet matrix is optimized for mechanical strength, moisture resistance, and shelf-life extension, making it suitable for long-term storage and transportation. Manufacturing processes focus on achieving homogenous blending, compression, and coating to maintain therapeutic integrity. The formulation adheres to pharmaceutical standards for multi-component tablets, ensuring compliance with excipient compatibility testing and dissolution rate specifications.

Manufacturing Capability

Our manufacturing infrastructure is equipped to produce Libride D with advanced pharmaceutical capabilities, including ISO-certified facilities, state-of-the-art sterile processing units, and compliance with Good Manufacturing Practice (GMP) standards. The production line supports high-speed tablet compression, automated blending, and precision coating technologies to ensure consistent quality. The facility is designed for scalability, enabling seamless transitions from small-scale trials to bulk production. Quality systems include real-time monitoring, environmental controls, and validated cleaning procedures to prevent cross-contamination. Our dedicated R&D team ensures formulation optimization for stability, disintegration, and dissolution, while advanced analytical tools such as HPLC and UV spectrophotometry are integrated into the manufacturing workflow.

Available Strengths and Packaging

Composition: Chlordiazepoxide 5mg+Clidinium Bromide 2.5mg+Dicyclomine Hydrochloride 10mg Tab

Packaging: 4x5x10 Blister

Libride D is available in a fixed-dose combination of 5mg, 2.5mg, and 10mg per tablet, ensuring precise dosing for therapeutic applications. The blister packaging (4x5x10) offers tamper-evident protection, moisture resistance, and ease of distribution. This format is ideal for pharmaceutical manufacturers requiring secure, compact packaging for retail or institutional use. The blister design also supports patient compliance through clear labeling and individual tablet compartments.

Contract Manufacturing / Third Party Manufacturing

As a trusted pharmaceutical manufacturer, we offer end-to-end contract manufacturing services for Libride D, including private label production and third-party manufacturing for global buyers. Our capabilities extend to custom formulation development, packaging design, and regulatory documentation, ensuring compliance with international standards. We support bulk production for large-scale distribution and provide flexible manufacturing options to meet diverse market demands. Our team collaborates closely with clients to align production schedules, quality specifications, and regulatory requirements, ensuring timely delivery of high-quality products.

Quality Assurance

Our quality assurance framework is built on rigorous analytical validation, batch testing, and adherence to pharmaceutical quality standards. Each batch of Libride D undergoes comprehensive testing, including dissolution rate analysis, disintegration time measurement, and active ingredient quantification via HPLC. Microbial contamination testing, heavy metal analysis, and pH compatibility assessments are conducted to ensure product safety. Quality control systems are integrated with real-time data monitoring, enabling traceability and process validation. We maintain documentation compliant with USP, EP, and ISO standards, ensuring transparency and reliability for pharmaceutical buyers.

Regulatory Compliance

Libride D is manufactured in full compliance with GMP, WHO guidelines, and global regulatory frameworks, including FDA, EMA, and PIC/S standards. Our facility holds certifications for ISO 9001 (quality management) and ISO 14001 (environmental management), ensuring adherence to international best practices. Regulatory documentation, including batch records, stability data, and analytical reports, is maintained to support market approval in target regions. We also ensure compliance with excipient and active pharmaceutical ingredient (API) regulations, providing clients with a seamless pathway to global distribution.

Global Supply Capability

We offer robust global supply capabilities, including export-ready manufacturing, international distribution networks, and bulk supply solutions for pharmaceutical buyers. Our logistics partners enable reliable delivery to over 50 countries, with storage facilities optimized for temperature and humidity control. Bulk supply capacity is scalable to meet large-scale demands, supported by a resilient supply chain with contingency planning. We prioritize on-time delivery, inventory management, and compliance with import regulations to ensure uninterrupted supply for distributors and exporters.

Why Choose Us

Pharmaceutical distributors, exporters, and contract manufacturing partners select us for our expertise in multi-ingredient formulations, compliance-driven manufacturing, and scalable production. Our commitment to quality, regulatory adherence, and innovation ensures reliable supply chains and competitive product offerings. With a dedicated B2B team, we provide tailored solutions, from formulation development to global distribution, empowering clients to meet market demands efficiently.

Bulk Supply Inquiry

For bulk supply inquiries, contact our team at info@delwishealthcare.com to discuss production timelines, packaging options, and compliance requirements.

FAQs

1. What is the composition of Libride D?

   Libride D contains Chlordiazepoxide 5mg, Clidinium Bromide 2.5mg, and Dicyclomine Hydrochloride 10mg per tablet.

2. Is Libride D available in different strengths?

   Libride D is formulated as a fixed-dose combination and is not available in variable strengths.

3. What packaging options are available for Libride D?

   The product is packaged in 4x5x10 blister packs for secure, tamper-evident distribution.

4. Does your facility comply with GMP standards?

   Yes, our manufacturing facilities are fully compliant with GMP, ISO 9001, and WHO guidelines.

5. Can you provide bulk supply for international markets?

   Yes, we offer bulk supply solutions with global distribution capabilities and compliance with international regulations.

6. What quality control measures are in place for Libride D?

   Each batch undergoes rigorous testing, including HPLC, dissolution testing, and microbial analysis, to ensure quality and safety.

7. Can you support private label manufacturing for Libride D?

   Yes, we provide private label manufacturing services tailored to client specifications and regulatory requirements.

8. What is the shelf life of Libride D?

   The product has a shelf life of 24 months when stored under recommended conditions (cool, dry, and protected from light).

9. How do you ensure compliance with global regulatory frameworks?

   We maintain documentation and certifications aligned with FDA, EMA, and PIC/S standards to support global market access.

10. Can you accommodate custom packaging designs?

    Yes, we offer flexible packaging solutions, including blister packs, to meet specific client requirements.